Cannabis finance news

Company news: Vitura Health; Puro; MGC Pharma; Incannex; Cann Global

by Steve Jones March 8, 2023April 30, 2024

Vitura Health Vitura Health will be included in the S&P/ASX All Ordinaries index from March 20 […]

Bod Science clears stability hurdle for Aqua Phase deal but PK study delayed

by Steve Jones March 7, 2023April 30, 2024

Medlab goes up for sale as directors appoint external consultants

by Steve Jones March 7, 2023April 30, 2024

Medlab cancels studies and directors depart as ASX suspends shares

by Steve Jones March 2, 2023April 30, 2024

Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira

by Martin Lane and Steve Jones March 1, 2023April 30, 2024

Company news: Eqalis/Novachem; Cann Group; Vitura Health; Incannex; Lyphe Group

by Steve Jones and Martin Lane March 1, 2023April 30, 2024

Cann Group to focus on ‘production at scale’ as new CEO beds down

by Steve Jones February 28, 2023April 30, 2024

ECS Botanics grows H1 revenue and cuts losses despite impact of heavy flooding

by Steve Jones February 28, 2023April 30, 2024

josh fegan

Althea losses rise but shareholders told to expect ‘significant upside’

by Steve Jones February 28, 2023April 30, 2024

Rise of THC flower hits Bod CBD sales as medical revenues fall 29%

by Steve Jones February 27, 2023April 30, 2024